Octapharma GmbH is one of the largest global healthcare companies in family ownership. Since 1983, the company has been developing medicines based on human plasma and cell lines at its headquarters in Switzerland. With a focus on hemophilia, immunology, and critical care, Octapharma provides patients in more than 120 countries with modern therapies aimed at improving long-term quality of life.